dilluns, 10 de febrer del 2014

CABANA trial morphs from mortality trial to composite endpoint trial




Westby G. Fisher, MD, FACC is a board certified internist, cardiologist, and cardiac electrophysiologist practicing at NorthShore University HealthSystem in Evanston, IL, USA and is a Clinical Associate Professor of Medicine at University of Chicago's Pritzker School of Medicine.





By Westby G. Fisher, MD, FACC


Westby Fisher

Major changes are underway for one of the signature comparative effectiveness research trials promoted by government interests on Capitol Hill as a critical path forward to controlling costs in health care. It seems such research might not be so easy and "cost-effective" as some had hoped.



read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1iSiSco

Cap comentari:

Publica un comentari a l'entrada